13F Holdings
中文EN

CITR CitroTech Inc.

Chemicals & Allied Products · NYSE · SEC CIK 894556 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-14.3%
TTM net income YoY43.2%
TTM EPS YoY78.7%
Revenue 3-yr CAGR87.7%
Net income 3-yr CAGR—

Margins

Gross margin23.6%
Operating margin-927.5%
Net margin-1,071.4%
FCF margin-447.2%
EBITDA margin-901.0%

Returns

ROE-235.3%
ROA-177.7%
ROIC (approx.)-293.9%
Asset turnover0.17x

Leverage & solvency

Liabilities / assets15.7%
Debt / equity0.00x
Current ratio2.99x
Interest coverage-44.68x

Cash quality & payout

Operating cash flow / net income0.42x
Accruals ratio-103.5%
Payout ratio—
Capex / revenue-0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.38M$808,372$520,645$62,732$0
Cost of revenue$1.85M$655,499$182,730$56,338$18,613
Gross profit$530,725$152,873$387,137$60,839$20,306
R&D expense$198,505$14,002$0——
SG&A expense$1.59M$498,445$256,602$256,686$3,672
Operating income-$16.50M-$5.30M-$10.10M-$2.92M-$37,909
Interest expense$1.51M$257,782$4,328$255$1,469
Pretax income-$36.84M-$6.88M-$10.10M-$2.92M-$44,973
Income tax$0$0$0$0$0
Net income-$36.84M-$6.88M-$10.10M-$2.91M-$94,973
EBITDA-$16.17M-$5.04M-$9.85M-$2.90M-$28,172
EPS (basic)-2.96-0.82-0.10-0.050.00
EPS (diluted)-2.96-0.82-0.100.000.00
Weighted avg. shares (diluted)12.44M8.38M96.66M75.27M22.95M
Balance sheet
Cash & equivalents$6.27M$775,133$549,755$55,434$5,469
Receivables$209,047$317,455$427,433$0—
Inventory$620,768$324,657$230,197$114,645$0
Current assets$7.42M$1.62M$1.22M$170,319$5,469
PP&E, net$630,279$111,374$7,299$4,547$291,438
Intangibles$5.33M$3.70M$3.95M$4.20M$33,324
Total assets$14.18M$5.48M$5.30M$4.41M$330,231
Current liabilities$2.17M$2.16M$1.62M$1.06M$383,090
Short-term debt—$96,849$0——
Long-term debt—$0———
Total debt—$96,849———
Total liabilities$2.92M$2.16M$1.67M$1.06M$383,090
Shareholders' equity$11.26M$3.32M$3.64M$3.35M-$52,859
Net debt—-$678,284———
Shares outstanding18.52M6.14M97.55M93.95M22.95M
Cash flow statement
Operating cash flow-$5.87M-$1.94M-$1.21M-$708,450-$24,206
Capital expenditure$193,953$0$4,015$5,350$0
Free cash flow-$6.06M-$1.94M-$1.22M-$713,800-$24,206
Investing cash flow-$293,953$0-$4,015-$5,349-$287,100
Financing cash flow$11.66M$2.16M$1.71M$763,764$316,775
Depreciation & amortization$329,334$264,696$248,510$15,862$9,737
Stock-based compensation$19.14M$3.06M$8.97M$2.10M$0

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.